Immunomedics CEO Michael Pehl hits the exit on the heels of a CRL and accusations of a data integrity breach

Following a rough few weeks, the revolving door at the executive suite to Immunomedics $IMMU is turning once more. After the market closed on Monday the company put out word that CEO Michael Pehl has decided to leave for personal reasons.